Indication

Renal osteodystrophy

Renal osteodystrophy is a skeletal complication of chronic kidney disease characterized by alterations in bone morphology and histology. Read more about Renal osteodystrophy

29 drugs 24 manufacturers

Advertisement

Drugs that treat it

Common Renal osteodystrophy therapies.

Showing 1–9 of 29 drugs

CALCITRIOL

VITAMIN D·HYPOPARATHYROIDISM·+5
ROXANE/WEST-WAR
Filter & compare in the drug finder →Opens the drug finder with Renal osteodystrophy preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Renal osteodystrophy.

Renal osteodystrophy is a skeletal complication of chronic kidney disease characterized by alterations in bone morphology and histology.

It represents the bone-specific component of the broader chronic kidney disease–mineral and bone disorder (CKD-MBD) syndrome.

Pathophysiologically driven by impaired renal phosphate excretion, reduced calcitriol synthesis, secondary hyperparathyroidism, and abnormal calcium homeostasis, the condition disrupts normal bone turnover, mineralization, and volume.

Definitive histologic classification via bone biopsy reveals a spectrum of lesions, including high-turnover osteitis fibrosa cystica, low-turnover adynamic bone disease or osteomalacia, and mixed forms, clinically manifesting as bone pain, skeletal deformities, and heightened fracture risk.

Personalize your experience

Follow Renal osteodystrophy and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it